A single-blind randomized phase III trial of MTA [pemetrexed] plus cisplatin versus cisplatin in patients with malignant pleural mesothelioma
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Cisplatin (Primary) ; Pemetrexed (Primary)
- Indications Malignant-mesothelioma
- Focus Therapeutic Use
- 09 Jan 2006 New trial record.